The recombinant monoclonal antibody is specific for acetylated LDL (AcLDL) and malondialdehyde-treated LDL (MDA-LDL). This mouse anti-LDL antibody (4E4) specifically binds to modified LDL present in human atherosclerotic lesions.
Figure 1 Anti-OxLDL monoclonal antibodies 4E4 distinguish between human OxLDL and native LDL.
Data are expressed as mean optical density ± standard error oftriplicates.
Boyd, H. C., Gown, A. M., Wolfbauer, G., & Chait, A. (1989). Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. The American journal of pathology, 135(5), 815.
Figure 2 Immunofluorescent detection of LDL in atherosclerotic lesions.
Original magnification X175.
Boyd, H. C., Gown, A. M., Wolfbauer, G., & Chait, A. (1989). Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. The American journal of pathology, 135(5), 815.
Figure 3 Reproduction of a Western blot analysis of the degree of LDL fragmentation and aggregation associated with different times of oxidation.
Reproduction of an agarose gel electrophoretogram of the samples separated by Western blot.
Lopes-Virella, M. F., Koskinen, S., Mironova, M., Horne, D., Klein, R., Chassereau, C., ... & Virella, G. (2000). The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA. Atherosclerosis, 152(1), 107-115.
Figure 4 Immunohistology of the adrenal gland stained with anti-LDL receptor antibody.
High power in zona fasciculata (X200).
Fong, L. G., Bonney, E., Kosek, J. C., & Cooper, A. D. (1989). Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver, and intestine. The Journal of clinical investigation, 84(3), 847-856.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-615 | Recombinant Anti-LDL Antibody | ELISA, WB, FC, FuncS | IgG |
MHH-615 | Recombinant Human Anti-LDL Antibody | ELISA, WB, FuncS | IgG |
MOB-0162MZ | Recombinant Mouse Anti-Human Low Density Lipoprotein Receptor-Related Protein (LRP) (515kDa) Antibody (clone 9H2) | WB, IHC-FoFr, FC | Mouse antibody |
HPAB-1067WJ | Recombinant Human Anti-LDL Antibody (IEIA8) | ELISA | Human IgG |
FAMAB-0185JF | Mouse Anti-LDL Recombinant Antibody (clone 1H11) | WB, ELISA, IHC, IF | Mouse IgG |
There are currently no Customer reviews or questions for FAMAB-0186JF. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.